Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

A subtle tool to study mankind’s diseases

25.03.2003


One of the most powerful tools in today’s biological and medical science is the ability to artificially remove and add bits of DNA to an organism’s genome. This has helped scientists to understand problems caused by defective genes, for example, which have now been linked to thousands of human diseases. So far the technology has been limited to small segments of DNA. But four years ago, Francis Stewart and his colleagues at the European Molecular Biology Laboratory (Heidelberg) developed a new technique to engineer greater stretches of DNA in bacteria. The researchers, now working at the Biotec-Technical University in Dresden, have just used this method to engineer a complex set of changes in a mouse gene, in hopes of shedding light on human leukemias. Their work appears in the current edition of the journal Nature Biotechnology.

Over two decades ago, researchers learned to use bacteria as "copy machines" for DNA taken from other organisms. This was a huge step for biotechnology, because most types of research require billions of copies of a molecule under investigation. However, there was a limitation: researchers need to change the DNA molecules in precise ways and for large molecules, such as whole genes, this was tremendously difficult.

Stewart and his colleagues thought that bacteria could be taught to do better, so they "borrowed" a strategy that organisms such as mice and yeast use to repair breaks in DNA. Proteins called recombinases circulate through their cells, looking for loose DNA fragments that have familiar sequences.



"Recombinases assume that the fragments have been cut out of the DNA by mistake, so they try to glue them back into the genome in the right place," says Giuseppe Testa, who headed the current study. "Sometimes they’re a bit over-industrious; they put in pieces that look right, such as variations of a gene that have been put into the cell by a researcher."

Called homologous recombination, this process works a bit like a "find-and-replace" command in your word processor. Imagine you have typed "Stephen Q. Gould" everywhere, and suddenly discover that the middle initial should be "J". The computer can be told to look for "Stephen" and "Gould" and replace what comes between them. In the same way, recombinases find recognizable sequences of DNA to the left and right of a target and replace what comes in between with the new sequence.

Homologous recombination was known to occur in bacteria, but it hadn’t been possible to use it to engineer DNA, as was the case in yeast and mouse stem cells. Stewart?s team decided to try to find a strain that could do it. "We ordered as many types of E. coli as we could, looking for defects in the way they repair their DNA," he says. "After five months of work, Youming Zhang, a postdoc in the lab, found the strain."

The group quickly identified the bacterial factors involved and turned them into a new tool called Red/ET recombination that is now being adopted by biologists all over the world. It’s one of the mainstays of Gene Bridges GmbH, a company that Stewart and his colleagues founded with EMBL to develop the commercial implications of the breakthrough.

"We have been pushing it to work with larger and larger bits of DNA," Testa says, "and our latest project has been to engineer an entire artificial chromosome in bacteria. We’ve constructed a large, complex ’cassette’ that we’ve now inserted into a mouse in place of its normal gene."

The gene that they chose is called mixed-lineage leukemia (Mll), and is known to become defective in childhood leukemias in humans. By inserting the artificial version into the mouse, researchers hope to understand how the defects lead to disease. "There are many things that can go wrong in this gene," Testa says, "and we wanted to construct a version of it that would allow us to test as many aspects of the problem as possible."

The artificial Mll that they have put into the mouse will permit a variety of experiments. It contains two defects in the genetic sequence that have been linked to leukemias. The cassette also contains control switches that allow each defect to be "switched on" whenever the researchers choose; they can also be left off. "We can study each mutation independently, or watch how they act together, or control the time at which each one acts," Testa says. "This will give us a new look at subtle relationships between multiple defects."

Many diseases are linked to single mutations; however, disease susceptibility also often relies on other sequence variations, known as polymorphisms, in the human population. "The Mll cassette shows, in principle, a simple way to study both a mutation and a related polymorphism in the gene of interest," Testa says. "This aspect of making mouse models will become increasingly more important for authentic modeling of human disease susceptibility and the way organisms respond to drugs and we think that our work shows the way to set up these models".

The new work also heralds a new era for genomic engineering in many living systems. "The Mll cassette is a first demonstration of what can be done with large DNA molecules," Stewart says. "Red/ET recombination increases the size of DNA that can be comfortably engineered by more than ten times and opens up new possibilities for genomic engineering that will filter into standard practice in the next few years."

Russ Hodge | EurekAlert!
Further information:
http://www.embl-heidelberg.de/

More articles from Life Sciences:

nachricht When Air is in Short Supply - Shedding light on plant stress reactions when oxygen runs short
23.03.2017 | Institut für Pflanzenbiochemie

nachricht WPI team grows heart tissue on spinach leaves
23.03.2017 | Worcester Polytechnic Institute

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

When Air is in Short Supply - Shedding light on plant stress reactions when oxygen runs short

23.03.2017 | Life Sciences

Researchers use light to remotely control curvature of plastics

23.03.2017 | Power and Electrical Engineering

Sea ice extent sinks to record lows at both poles

23.03.2017 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>